Trials / Terminated
TerminatedNCT02183246
Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients
A Phase III, Double-Blind, Randomized, Placebo-Controlled Study of Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Determination of efficacy and safety of porfiromycin versus placebo as an adjuvant to radiotherapy in postoperative head and neck a cancer patients as well as assessment of population pharmacokinetic parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Porfiromycin | |
| DRUG | Placebo | |
| RADIATION | Radiotherapy |
Timeline
- Start date
- 2000-05-01
- Primary completion
- 2000-12-01
- First posted
- 2014-07-08
- Last updated
- 2014-07-08
Source: ClinicalTrials.gov record NCT02183246. Inclusion in this directory is not an endorsement.